Evidence map›Paper›PMID 40662024›Full record

ReviewCureus2025

Challenges and Strategies in Medication Management for Patients With Multiple Comorbidities.

Ayomide H Adeyemi, Bernard Wiredu, Okelue E Okobi, Peter Nebuwa, Esther I Ezeani, Amaka S Alozie

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayomide H AdeyemiMedicine, VN Karazin Kharkiv National University, Kharkiv, UKR.
Bernard WireduMedicine, Saint James School of Medicine, Arnos Vale, VCT.
Okelue E OkobiFamily Medicine, IMG Research Academy & Consulting LLC, Homestead, USA.
Peter NebuwaInternal Medicine, College of Health Sciences, Nnamdi Azikwe University, Nnewi, NGA.
Esther I EzeaniFamily Medicine, Indiana Regional Medical Center (IRMC), Indiana, USA.
Amaka S AlozieMedicine, Abia State University, Uturu, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the global population ages, polypharmacy-the concurrent use of multiple medications-has become increasingly common among older adults with multiple chronic conditions. While often clinically necessary, polypharmacy is associated with significant challenges, including medication nonadherence, adverse drug events, and increased hospitalizations. This narrative review synthesizes current evidence to explore the burden of polypharmacy, identify barriers to safe medication use, and assess intervention strategies aimed at improving outcomes in older adults. Drawing from diverse sources including clinical trials, observational studies, and policy reports, this review highlights the multifaceted nature of medication management in older adults. Contributing factors to nonadherence include cognitive decline, regimen complexity, low health literacy, and fragmented care. Interventions such as pharmacist-led medication reviews, deprescribing initiatives, motivational interviewing, and digital health tools have demonstrated potential in improving adherence and therapeutic safety. Emerging approaches-including pharmacogenomic-guided prescribing and AI-driven clinical decision support-also offer promising avenues for personalized care. A comprehensive, multidisciplinary framework that incorporates patient-centered communication, integrated care models, and supportive policy infrastructure is essential for addressing the complexities of polypharmacy in older populations. Continued research and collaboration across healthcare disciplines will be critical to translating these strategies into routine practice and enhancing medication safety for this vulnerable demographic.

Indexed as

artificial intelligence in healthcarecollaborative approachdeprescribingdigital health educationmedication adherencemedication managementmultimorbidity managementolder adultpharmacogenomicspolypharmacy

Identifiers

PMID40662024
PMCPMC12257869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.